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Radicals formed by SmI2eH2O-mediated electron transfer to the carbonyl group of unsaturated ﬁve-
membered lactones undergo diastereoselective cyclisation to give cyclohexane-1,4-diols. The use of
HMPA as an additive with SmI2eH2O gave improved conversion and diastereoselectivity in the
cyclisations.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).SmI2–H2O
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B. This work: SmI2–H2O in radical cyclisations of five-membered lactones
A. Cyclohexan-1,4-diol motifs in bioactive natural products
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Oxygenated cyclohexanes are ubiquitous substructures among
complex terpenes with a high biological proﬁle and new stereo-
selective methods for their facile formation are always in demand
(Fig. 1A).1e6 Samarium diiodide (Kagan’s reagent, SmI2)7 has a long
track record in the selective formation of carbonecarbon bonds.8
We have recently expanded the already large repertoire of SmI2
by developing new substrate activation modes involving electron
transfer (ET) to carboxylic acid derivatives using SmI2eH2O under
mild conditions.9 This discovery has led to our development of
novel functional group transformations10e17 and highly selective
radical cyclisation processes involving carbonecarbon bond
formation.10b,11a,17e20
The reactivity of the radical anion formed during the SmI2eH2O-
promoted reduction of carboxylic acid derivatives is a key factor in
these reactions.9 For example, in the reduction of lactones using
SmI2eH2O, radical intermediates are stabilised by hyper-
conjugation with the neighbouring oxygen atoms and also by
H2O.10a,10b,10d We recently demonstrated that the ﬁrst electron
transfer to the lactone carbonyl is reversible for lactones of various
ring sizes10d,16 and this reversibility can limit the ability to do
productive chemistry. For example, six-membered lactones can be
reduced to diols using SmI2eH2O as the intermediate radical anions31 2
R OHR
Fig. 1. A. Selected natural products containing cyclohexane-1,4-diol motifs. B. Radical
cyclisation of ﬁve-membered lactones using SmI2eH2O.
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bered lactones to diols, however, cannot be achieved with
SmI2eH2O as the corresponding radical anions undergo back ET to
Sm(III).10a,10b,10d Nevertheless, reductive transformations of ﬁve-
membered lactones 1 using SmI2eH2O may be possible if the
radical anion 2 could be efﬁciently trapped by an appropriately
placed radical acceptor prior to back ET to Sm(III). Importantly,
trapping radical anions 2 would result in carbonecarbon bond
formation and deliver cyclohexan-1,4-diols 3 after in situ reduction
of a cyclohexanone intermediate (Fig.1B). Herewe describe the ﬁrst
cyclisations of simple ﬁve-membered lactones triggered by single
ET to the lactone carbonyl.2. Optimisation of the cyclisation
The feasibility of the radical cyclisation was assessed using the
ﬁve-membered lactone 1a (Table 1). Pleasingly, cyclisation product
3awas formed cleanly using SmI2eH2O, with only traces of acyclic
diol byproduct 4a formed. Increasing the amount of H2O from 800
to 1600 equiv (100 and 200 equiv wrt SmI2, respectively; entries 1
and 2) did not affect the conversion or the diastereoselectivity of
the reaction. Higher amounts of H2O, however, had an increasingly
detrimental effect on both conversion and diastereoselectivity
(entries 3 and 4), and a larger amount of reduction product 4awas
also observed. The recovery of starting material after treatment
with excess SmI2 highlights the low reactivity of the radical anion
intermediate (cf. 2) and the reversibility of the ET step. Long re-
action times and variable conversion using SmI2eH2O prompted us
to screen different additives. First, we observed that the addition of
NEt321 to SmI2eH2O had a beneﬁcial effect, showing full conversion
and higher yields of 3a (entries 5e8), however, signiﬁcantly lower
diastereoselectivity was observed. The use of low amounts of NEt3
additive resulted in low conversion and the original diaster-
eoselectivity was reestablished (entries 9 and 10). We have pre-
viously shown that SmI2eH2O and NEt3 can reduce all lactones to
diols.10cTable 1
Optimisation of the radical cyclisation of ﬁve-membered lactone 1a
Entry H2O (equiv) Additive (equiv) 1a (%)a Conversion (%)a
3a (dr)a 4a
1 800b d 34 65 (88:12) 1
2 1600b d 33 63 (88:12) 4
3 2400 d 33 57 (81:19) 9
4 3200 d 58 33 (74:16) 9
5 800 NEt3 (60) d 97 (74:16) 3
6 800 NEt3 (30) d 86 (71:29) 14
7 800 NEt3 (15) d 94 (72:28) 6
8 800 NEt3 (8) d 86 (77:23) 14
9 800 NEt3 (4) 24 69 (79:21) 7
10 800 NEt3 (1) 44 53 (86:14) 3
11 800 HMPA (8) 16 81 (88:12) 3
12 800 HMPA (16) 5 93 (87:13) 2
13 800b HMPA (32) 36 64 (90:10) d
14 800b HMPA (64) 21 79 (92:8) d
Conditions: 1a (1 equiv), SmI2 (8 equiv), H2O (see table), additive (see table), THF, rt.
a Conversions and diastereoisomeric ratios determined by NMR analysis.
b An average of multiple runs.Finally, we investigated the effect of HMPA as an additive22 with
SmI2eH2O. Pleasingly, the addition of HMPA had a positive effect on
the conversion of 1a into 3a (entries 11e14) and greater diaster-
eoselectivity was observed at higher concentrations of HMPA.3. Scope of the cyclisation
With various effective cyclisation conditions in hand, we next
synthesised a range of lactone substrates to assess the generality of
the process: easily accessible lactone 523 underwent cross-me-
tathesis24 with various styrenes to give lactones 1aei in moderate
to good isolated yield (Scheme 1).Scheme 1. Synthesis of lactone cyclisation substrates 1ae1i.Substrates 1aei underwent cyclisation upon treatment with
SmI2eH2O and SmI2eH2OeHMPA (Scheme 2). In most cases,
oxidation of the cyclisation products 3 using the DesseMartin
periodinane (DMP) was used to simplify isomeric mixtures and
clarify the diastereoselectivity of the cyclisation event. This
transformation also offers a versatile platform to access other
compounds of signiﬁcant synthetic potential.25 X-ray crystallo-
graphic analysis of 6a and 6b conﬁrmed the relative conﬁguration
of the major diastereoisomers arising from the cyclisation
(Fig. 2).26 Conversion was found to be inconsistent when
SmI2eH2O was used possibly due to variability in the decay of
Sm(II) over the extended reaction times. When HMPAwas used as
an additive, higher conversion and higher diastereoselectivity
were observed. Substitution in all positions of the aryl substituent
on the alkene was tolerated and products were obtained in
moderate to good isolated yields. Interestingly, lactones 1b and
1c containing a halide substituent in the 2-position of the aryl
group on the alkene, gave the corresponding cyclisation products
6b and 6c, respectively, with higher diastereocontrol than that
observed for other substrates. Furthermore, the use of HMPA as
an additive increased the selectivity of the cyclisations of 1b and
1c, and 6b and 6c were obtained in 95:5 dr and 93:7 dr,
respectively.
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Scheme 3. Proposed mechanism for the SmI2eH2O promoted radical cyclisation of
ﬁve-membered lactones and a possible role for HMPA.
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Conditions A: 1 (1 equiv), SmI2 (8 equiv), H2O (800 equiv), THF, rt.
Conditions B: 1 (1 equiv), SmI2 (8 equiv), H2O (800 equiv), HMPA (64 
equiv), THF, rt. a Conversion. Conversion and diastereoisomeric ratio were
determined by NMR analysis after radical cyclisation. bYields in brackets are 
of isolated 6 after radical cyclisation and subsequent DMP oxidation.
Scheme 2. Radical cyclisation of ﬁve-membered lactones using SmI2eH2O.Fig. 2. X-ray crystallographic analysis of 6a and 6b.The cyclisation appears to proceed through the mechanism
shown in Scheme 3A for 1a: the radical anion intermediate un-
dergoes cyclisation though the transition structure I to give radical
II, which is then further reduced and protonated to furnish 3a.4. Discussion
The use of additives such as NEt321 and HMPA22 is known to
generate more-reducing Sm(II) reagents in situ. In this case, how-
ever, the higher conversion observed when adding NEt3 and HMPA
to the reaction likely results from the additives promoting the rate-
determining cyclisation of radical anion intermediates 2 (vide in-
fra). In this regard, it is important that the Sm(II) reagent is tuned to
limit the rate of ET reduction of 2 and generation of acyclic diols 4.
The use of HMPA as an additive with SmI2eH2O, not only led to
higher conversion but also gave higher diastereoselectivities in the
radical cyclisations. Flowers has investigated the post-ET role of
HMPA in the intramolecular addition of ketyl radicals to alkenes
and has proposed that HMPA activates ketyl radicals by seques-
tering Sm(III) and generating a dissociated ion pair that is more
reactive in carbonecarbon bond formation.22d A similar HMPA ef-
fect could account for the higher conversions observed usingSmI2eH2O and HMPA in the cyclisation of ﬁve-membered lactones
1: excess HMPA generates dissociated radical ion pair 20 that un-
dergoes facile cyclisation. Enhanced selectivity in the cyclisation of
1 may result from the increased steric bulk associated with Sm(III)
when HMPA is present. Thus, more sterically encumbered in-
termediates 2/20 lead to better diastereocontrol in the formation of
3 (Scheme 3B).22d Enhanced diastereocontrol upon the use of
HMPA in conventional SmI2-mediated intramolecular additions of
ketyl radicals to alkenes has been reported.22,27
5. Conclusion
Radicals formed by SmI2eH2O-mediated electron transfer to the
carbonyl group of unsaturated ﬁve-membered lactones undergo
diastereoselective cyclisation to give cyclohexane-1,4-diols. The use
of HMPA as an additive with SmI2eH2O gave improved conversion
and diastereoselectivity in the cyclisations.
6. Experimental section
6.1. General information
THF, NEt3 and CH2Cl2 were freshly distilled before use. THF was
distilled over sodium wire and benzophenone; CH2Cl2 and NEt3
were distilled over calcium hydride. All other solvents and reagents
used were purchased from commercial suppliers and used
according to relevant guidelines. 1H NMR spectra were obtained at
room temperature on a 400 MHz or 500 MHz spectrometer. 13C
NMR spectra were obtained at 101 or 126 MHz, respectively.
Chemical shifts are reported in parts per million (ppm) and cou-
pling constants (J) reported in Hz. Splitting patterns are reported as
follows: singlet (s), doublet (d), triplet (t), doublet of doublets of
triplets (ddt), doublet of doublets of doublets (ddd) and multiplet
X. Just-Baringo et al. / Tetrahedron 72 (2016) 7691e76987694(m). IR data was obtained from neat products and values are re-
ported in cm1. TLC analysis was carried out on aluminium sheets
coated with silica gel and visualised using potassium permanga-
nate solution and/or UV light.
6.2. 5-Allyl-5-methyldihydrofuran-2(3H)-one (5)
According to the procedure reported in the literature,23 zinc
granules (1.6 g, 24.4 mmol) were added to a stirring solution of allyl
bromide (1.7 mL, 23.4 mmol) and methyl levuliate (2.0 mL,
16.2 mmol) in undried DMF (16mL) under air at room temperature.
After 15 min, an exotherm was observed which subsided after
30 min. The reaction mixture was poured onto saturated aqueous
NH4Cl (300 mL) and extracted with Et2O (350 mL). The combined
organic layers were dried (MgSO4) and concentrated. The crude
product was puriﬁed by silica gel column chromatography (hexane/
EtOAc, 85:15 to 80:20) to yield the title product as a yellowish oil
(1.69 g, 12.2 mmol, 75%). 1H NMR (400 MHz, CDCl3) d 1.40 (s, 3 H,
CH3), 1.90e2.02 (m, 1 H, CHaHbCH2C(O)O), 2.09e2.23 (m, 1 H,
CHaHbCH2C(O)O), 2.42 (d, J¼6.8 Hz, 2 H, CH2CH]CH2), 2.58e2.67
(m, 2 H, CH2C(O)O), 5.12e5.22 (m, 2 H, CH2CH]CH2), 5.72e5.86 (m,
1H, CH2CH]CH2) ppm; 13CNMR (100MHz, CDCl3) d 26.1 (CH3), 29.1
(CH2CH2C(O)O), 32.1 (CH2CH2C(O)O), 45.2 (CH2CH]CH2), 85.9 (C),
119.8 (CH]CH2), 132.0 (CH]CH2), 176.6 (C(O)) ppm; IR nmax (thin
ﬁlm/cm1): 3078, 2978, 2934, 1764 (C]O), 1199, 1155, 1138, 939;
HRMS calcd for C8H12O2Na [MþNa]þ: 163.0735, found 163.0742.
6.3. General procedure A: cross-metathesis
6.3.1. 5-Cinnamyl-5-methyldihydrofuran-2(3H)-one (1a). To a solu-
tion of lactone 5 (100 mg, 0.713 mmol) and styrene (245 mL,
2.14 mmol) in degassed CH2Cl2 (1.8 mL) was added Hoveydae
Grubbs second generation catalyst (4 mg, 7.10 mmol). The resulting
solution was stirred at room temperature under a stream of ni-
trogen for 27 h. Solvent was removed under vacuum and the
resulting crude was puriﬁed by silica gel column chromatography
(hexane/EtOAc, 100:0 to 90:10). The title product was obtained as
a yellowish oil (91mg, 0.421mmol, 59%). 1H NMR (400MHz, CDCl3)
d 1.46 (s, 3 H, CH3), 1.96e2.06 (m, 1 H, CHaHbCH2C(O)O), 2.16e2.26
(m, 1 H, CHaHbCH2C(O)O), 2.52e2.69 (m, 4 H, 2CH2), 6.19 (dt,
J¼15.6, 7.6 Hz, 1 H, CH]CHPh), 6.51 (d, J¼15.6 Hz, 1 H, CH]CHPh),
7.22e7.27 (m, 1 H, ArH), 7.29e7.39 (m, 4 H, ArH) ppm; 13C NMR
(100 MHz, CDCl3) d 26.3 (CH3), 29.1 (CH2CH2C(O)O), 32.3
(CH2CH2C(O)O), 44.4 (CH2CH]CHPh), 86.3 (C), 123.4 (CH]CHPh),
126.2 (AreCH), 127.6 (AreCH), 128.6 (AreCH), 134.6 (CH]CHPh),
136.8 (AreC), 176.6 (C(O)) ppm; IR nmax (thin ﬁlm/cm1): 3027,
2974, 1763 (C]O), 1449, 1176, 939; HRMS calcd for C14H16O2Na
[MþNa]þ: 239.1048, found 239.1049.
6.3.2. (E)-5-(3-(2-Chlorophenyl)allyl)-5-methyldihydrofuran-2(3H)-
one (1b). Prepared according to general procedure A using 5
(100 mg, 0.713 mmol), 2-chlorostyrene (275 mL, 2.14 mmol) and
HoveydaeGrubbs second generation catalyst (4 mg, 7.10 mmol) in
degassed CH2Cl2 (1.8 mL). The crude product was puriﬁed by silica
gel column chromatography (hexane/EtOAc, 100:0 to 90:10). The
title product was obtained as a white solid (140 mg, 0.556 mmol,
78%): mp (CH2Cl2) 48e50 C. 1H NMR (400 MHz, CDCl3) d 1.47 (s,
3 H, CH3), 2.03 (ddd, J¼12.8, 9.6, 6.8 Hz, 1 H, CHaHbCH2C(O)O), 2.23
(ddd, J¼12.8, 9.2, 8.0 Hz, 1 H, CHaHbCH2C(O)O), 2.54e2.71 (m, 4 H,
2CH2), 6.18 (dt, J¼15.6, 7.6 Hz, 1 H, CH]CHAr), 6.69 (d, J¼15.6 Hz,
1 H, CH]CHAr), 7.16e7.26 (m, 2 H, ArH), 7.36 (dd, J¼7.6, 1.6 Hz, 1 H,
ArH), 7.51 (td, J¼7.4, 1.8 Hz, 1 H, ArH) ppm; 13C NMR (100 MHz,
CDCl3) d 26.3 (CH3), 29.1 (CH2C(O)O), 32.3 (CH2CH2C(O)O), 44.5
(CH2CH]CHAr), 86.1 (C), 126.5 (CH]CHAr), 126.8 (ArCH), 126.9
(ArCH), 128.6 (ArCH), 129.7 (ArCH), 130.8 (CH]CHAr), 132.8 (ArC),
135.0 (ArCCl), 176.6 (C(O)O) ppm; IR nmax (thin ﬁlm/cm1): 2931,1754 (C]O), 1469, 1172, 1092; HRMS calcd for C14H16O2Cl [MþH]þ:
251.0833, found 251.0839.
6.3.3. (E)-5-(3-(2-Fluorophenyl)allyl)-5-methyldihydrofuran-2(3H)-
one (1c). Prepared according to general procedure A using 5
(100 mg, 0.713 mmol), 2-ﬂuorostyrene (255 mL, 2.14 mmol) and
HoveydaeGrubbs second generation catalyst (4 mg, 7.10 mmol) in
degassed CH2Cl2 (1.8 mL). The crude product was puriﬁed by silica
gel column chromatography (hexane/EtOAc, 100:0 to 90:10). The
title product was obtained as a dark oil (112 mg, 0.478 mmol, 67%).
1H NMR (400 MHz, CDCl3) d 1.44 (s, 3 H, CH3), 1.99 (ddd, J¼13.0, 9.4,
6.8 Hz, 1 H, CHaHbCH2C(O)O), 2.19 (ddd, J¼13.0, 9.2, 8.0 Hz, 1 H,
CHaHbCH2C(O)O), 2.52e2.68 (m, 4 H, 2CH2), 6.24 (dt, J¼15.8,
7.2 Hz, 1 H, CH]CHAr), 6.63 (d, J¼15.8 Hz, 1 H, CH]CHAr), 7.01
(ddd, J¼10.8, 8.0, 1.0 Hz, 1 H, ArH), 7.08 (td, J¼8.0, 1.0 Hz, 1 H, ArH),
7.19 (m, 1 H, ArH), 7.41 (td, J¼8.0, 1.6 Hz, 1 H, ArH) ppm; 13C NMR
(100 MHz, CDCl3) d 26.3 (CH3), 29.1 (CH2C(O)O), 32.3 (CH2CH2C(O)
O), 44.8 (CH2CH]CHPh), 86.1 (C), 115.7 (d, J¼22.0 Hz, ArCH), 124.1
(d, J¼3.6 Hz, ArCH), 124.6 (d, J¼12.1 Hz, ArC), 126.2 (d, J¼4.7 Hz,
CH]CHAr), 127.0 (d, J¼2.6 Hz, CH]CHAr), 127.3 (d, J¼3.7 Hz,
ArCH), 128.9 (d, J¼8.3 Hz, ArCH), 160.0 (d, J¼247.4 Hz, ArCF), 176.6
(C(O)O) ppm; IR nmax (thin ﬁlm/cm1): 2976, 1764 (C]O), 1486,
1227, 1184, 940; HRMS calcd for C14H15O2FNa [MþNa]þ: 257.0948,
found 257.0951.
6.3.4. (E)-5-Methyl-5-(3-(4-(triﬂuoromethyl)phenyl)allyl)dihy-
drofuran-2(3H)-one (1d). Prepared according to general procedure
A using 5 (100mg, 0.713mmol), 4-(triﬂuoromethyl)styrene (315 mL,
2.14 mmol) and HoveydaeGrubbs second generation catalyst
(4 mg, 7.10 mmol) in degassed CH2Cl2 (1.8 mL). The crude product
was puriﬁed by silica gel column chromatography (hexane/EtOAc,
100:0 to 80:20). The title product was obtained as a yellowish oil
(140mg, 0.492 mmol, 69%). 1H NMR (400MHz, CDCl3) d 1.46 (s, 3 H,
CH3), 1.99e2.08 (m, 1 H, CHaHbCH2C(O)O), 2.20 (ddd, J¼13.2, 9.6,
7.6 Hz, 1 H, CHaHbCH2C(O)O), 2.54e2.71 (m, 4 H, 2CH2), 6.31 (dt,
J¼15.8, 7.6 Hz, 1 H, CH]CHAr), 6.54 (d, J¼15.8 Hz, 1 H, CH]CHAr),
7.46 (d, J¼8.0 Hz, 2 H, ArH), 7.58 (d, J¼8.0 Hz, 2 H, ArH) ppm; 13C
NMR (100 MHz, CDCl3) d 26.2 (CH3), 29.1 (CH2C(O)O), 32.5
(CH2CH2C(O)O), 44.4 (CH2CH]CHAr), 86.0 (C), 124.2 (q, J¼270.2 Hz,
CF3), 125.6 (q, J¼3.8 Hz, ArCH), 126.3 (CH]CHAr) 126.4 (ArCH),
129.5 (q, J¼32.3 Hz, ArCCF3), 133.3 (CH]CHAr), 140.3 (ArC), 176.5
(C(O)O) ppm; IR nmax (thin ﬁlm/cm1): 2978, 1766 (C]O), 1323,
1162, 1109, 1066; HRMS calcd for C15H19O2NF3 [MþNH4]þ:
302.1362, found 302.1366.
6.3.5. (E)-5-(3-(4-Bromophenyl)allyl)-5-methyldihydrofuran-2(3H)-
one (1e). Prepared according to general procedure A using 5
(100 mg, 0.713 mmol), 4-bromostyrene (280 mL, 2.14 mmol) and
HoveydaeGrubbs second generation catalyst (4 mg, 7.10 mmol) in
degassed CH2Cl2 (1.8 mL). The crude product was puriﬁed by silica
gel column chromatography (hexane/EtOAc, 100:0 to 85:15). The
title product was obtained as a pale solid (68mg, 0.228mmol, 32%):
mp (CH2Cl2) 53e55 C. 1H NMR (400 MHz, CDCl3) d 1.45 (s, 3 H,
CH3), 2.02 (ddd, J¼12.9, 9.6, 6.8 Hz,1 H, CHaHbCH2C(O)O), 2.20 (ddd,
J¼12.9, 9.4, 7.6 Hz, 1 H, CHaHbCH2C(O)O), 2.52e2.71 (m, 4 H,
2CH2), 6.19 (dt, J¼15.6, 7.6 Hz, 1 H, CH]CHAr), 6.44 (d, J¼15.6 Hz,
1 H, CH]CHAr), 7.23 (d, J¼8.4 Hz, 2 H, ArH), 7.44 (d, J¼8.4 Hz, 2 H,
ArH) ppm; 13C NMR (100MHz, CDCl3) d 26.2 (CH3), 29.1 (CH2C(O)O),
32.4 (CH2CH2C(O)O), 44.4 (CH2CH]CHAr), 86.1 (C), 121.3 (ArCBr),
124.3 (CH]CHAr), 127.7 (ArCH), 131.7 (ArCH), 133.4 (CH]CHAr),
135.7 (ArC), 176.6 (C(O)O) ppm; IR nmax (neat/cm1): 2975, 2932,
2905, 1758 (C]O), 1486, 1188, 1179, 938; HRMS calcd for
C14H15O2BrNa [MþNa]þ: 317.0153, found 317.0166.
6.3.6. (E)-5-Methyl-5-(3-(p-tolyl)allyl)dihydrofuran-2(3H)-one
(1f). Prepared according to general procedure A using 5 (100 mg,
X. Just-Baringo et al. / Tetrahedron 72 (2016) 7691e7698 76950.713 mmol), 4-methylstyrene (282 mL, 2.14 mmol) and Hovey-
daeGrubbs second generation catalyst (4 mg, 7.10 mmol) in
degassed CH2Cl2 (1.8 mL). The crude product was puriﬁed by silica
gel column chromatography (hexane/EtOAc, 100:0 to 80:20). The
title product was obtained as a white solid (62 mg, 0.271 mmol,
38%): mp (CH2Cl2) 66e67 C. 1H NMR (400 MHz, CDCl3) d 1.45 (s,
3 H, CH3), 1.99 (ddd, J¼12.9, 9.4, 7.0 Hz, 1 H, CHaHbCH2C(O)O), 2.21
(ddd, J¼12.9, 9.2, 7.8 Hz, 1 H, CHaHbCH2C(O)O), 2.34 (s, 3 H, ArCH3),
2.48e2.70 (m, 4 H, 2CH2), 6.13 (dt, J¼15.8, 7.6 Hz, 1 H, CH]CHAr),
6.47 (d, J¼15.8 Hz, 1 H, CH]CHAr), 7.13 (d, J¼8.0 Hz, 2 H, ArH), 7.26
(d, J¼8.0 Hz, 2 H, ArH) ppm; 13C NMR (100 MHz, CDCl3) d 21.2
(ArCH3), 26.3 (CH3), 29.2 (CH2C(O)O), 32.3 (CH2CH2C(O)O), 44.4
(CH2CH]CHAr), 86.4 (C), 122.3 (CH]CHAr), 126.1 (ArCH), 129.3
(ArCH),134.1 (ArCCH3),134.4 (CH]CHAr),137.4 (ArC), 176.7 (C(O)O)
ppm; IR nmax (neat/cm1): 2973, 2896, 1755 (C]O), 1191, 1013, 938;
HRMS calcd for C15H18O2Na [MþNa]þ: 253.1199, found 253.1200.
6.3.7. (E)-5-Methyl-5-(3-(m-tolyl)allyl)dihydrofuran-2(3H)-one
(1g). Prepared according to general procedure A using 5 (100 mg,
0.713 mmol), 3-methylstyrene (285 mL, 2.14 mmol) and Hovey-
daeGrubbs second generation catalyst (4 mg, 7.10 mmol) in
degassed CH2Cl2 (1.8 mL). The crude product was puriﬁed by silica
gel column chromatography (hexane/EtOAc, 100:0 to 90:10). The
title product was obtained as a yellowish oil (79 mg, 0.342 mmol,
48%). 1H NMR (400 MHz, CDCl3) d 1.46 (s, 3 H, CH3), 2.00 (ddd,
J¼12.9, 9.6, 7.0 Hz, 1 H, CHaHbCH2C(O)O), 2.21 (ddd, J¼12.9, 9.2,
8.0 Hz, 1 H, CHaHbCH2C(O)O), 2.36 (s, 3 H, ArCH3), 2.52e2.69 (m,
4 H, 2CH2), 6.18 (dt, J¼16.0, 7.2 Hz, 1 H, CH]CHAr), 6.48 (d,
J¼16.0 Hz,1 H, CH]CHAr), 7.07 (d, J¼7.2 Hz,1 H, ArH), 7.14e7.24 (m,
3 H, ArH) ppm; 13C NMR (100 MHz, CDCl3) d 21.4 (ArCH3), 26.3
(CH3), 29.1 (CH2C(O)O), 32.3 (CH2CH2C(O)O), 44.4 (CH2CH]CHAr),
86.3 (C), 123.1 (CH]CHAr), 123.4 (ArCH), 126.8 (ArCH), 128.4
(ArCH), 128.5 (ArCH), 134.6 (CH]CHAr), 136.8 (ArCCH3), 138.2
(ArC), 176.7 (C(O)O) ppm; IR nmax (neat/cm1): 2974, 1765 (C]O),
1454, 1177, 938; HRMS calcd for C15H19O2 [MþH]þ: 231.1380, found
231.1381.
6.3.8. (E)-5-(3-(2,5-Dimethylphenyl)allyl)-5-methyldihydrofuran-
2(3H)-one (1h). Prepared according to general procedure A using 5
(100 mg, 0.713 mmol), 2,5-dimethylstyrene (313 mL, 2.14 mmol)
and HoveydaeGrubbs second generation catalyst (4 mg, 7.10 mmol)
in degassed CH2Cl2 (1.8 mL). The crude product was puriﬁed by
silica gel column chromatography (hexane/EtOAc, 100:0 to 90:10).
The title product was obtained as a colourless oil (96 mg,
0.321 mmol, 45%). 1H NMR (400 MHz, CDCl3) d 1.47 (s, 3 H, CH3),
1.97e2.07 (m, 1 H, CHaHbCH2C(O)O), 2.19e2.28 (m, 1 H,
CHaHbCH2C(O)O), 2.30 (s, 3 H, ArCH3), 2.32 (s, 3 H, ArCH3),
2.55e2.71 (m, 4 H, 2CH2), 6.05 (dt, J¼15.6, 7.8 Hz, 1 H, CH]CHAr),
6.48 (d, J¼15.6 Hz, 1 H, CH]CHAr), 6.99 (d, J¼7.8 Hz, 1 H, ArH), 7.04
(d, J¼7.8 Hz, 1 H, ArH), 7.23 (s, 1 H, ArH) ppm; 13C NMR (100 MHz,
CDCl3) d 19.3 (ArCH3), 21.0 (ArCH3), 26.3 (CH3), 29.2 (CH2C(O)O),
32.3 (CH2CH2C(O)O), 44.7 (CH2CH]CHAr), 86.3 (C), 124.5 (CH]
CHAr), 126.2 (ArCH), 128.3 (ArCH), 130.2 (ArCH), 132.1 (ArCCH3),
132.6 (CH]CHAr), 135.5 (ArCCH3), 135.8 (ArC), 176.7 (C(O)O) ppm;
IR nmax (neat/cm1): 2974, 2928, 1766 (C]O), 1455, 1177, 938;
HRMS calcd for C16H20O2Na [MþNa]þ: 267.1361, found 267.1365.
6.3.9. (E)-5-Methyl-5-(3-(naphthalen-2-yl)allyl)dihydrofuran-
2(3H)-one (1i). Prepared according to general procedure A using 5
(100 mg, 0.713 mmol), 2-vinylnaphthalene (330 mL, 2.14 mmol) and
HoveydaeGrubbs second generation catalyst (4 mg, 7.10 mmol) in
degassed CH2Cl2 (1.8 mL). The crude product was puriﬁed by silica
gel column chromatography (hexane/EtOAc, 100:0 to 80:20). The
title product was obtained as a yellowish solid (99 mg, 0.371 mmol,
52%): mp (CH2Cl2) 91e93 C. 1H NMR (400 MHz, CDCl3) d 1.49 (s,
3 H, CH3), 2.03 (ddd, J¼12.8, 9.6, 6.8 Hz, 1 H, CHaHbCH2C(O)O),2.20e2.30 (m, 1 H, CHaHbCH2C(O)O), 2.56e2.72 (m, 4 H, 2CH2),
6.32 (dt, J¼15.6, 7.6 Hz,1 H, CH]CHAr), 6.67 (d, J¼15.6 Hz,1 H, CH]
CHAr), 7.41e7.50 (m, 2 H, ArH), 7.59 (dd, J¼8.4, 1.6 Hz,1 H, ArH), 7.72
(s, 1 H, ArH), 7.76e7.83 (m, 3 H, ArH) ppm; 13C NMR (100 MHz,
CDCl3) d 26.3 (CH3), 29.2 (CH2CH2C(O)O), 32.4 (CH2CH2C(O)O), 44.6
(CH2CH]CHAr), 86.3 (C), 123.4 (ArCH), 123.8 (CH]CHAr), 125.9
(ArCH),126.0 (ArCH),126.3 (ArCH),127.7 (ArCH),127.9 (ArCH),128.3
(ArCH), 133.0 (ArC), 133.6 (ArC), 134.3 (ArC), 134.7 (CH]CHAr),
176.6 (C(O)) ppm; IR nmax (neat/cm1): 2924, 1765 (C]O), 1455,
1185, 985, 936; HRMS calcd for C18H18O2Na [MþNa]þ: 289.1204,
found 289.1218.
6.3.10. (E)-4-Methyl-7-phenylhept-6-ene-1,4-diol (4a). LiAlH4 (39 mg,
1.02 mmol) was added to a stirred solution of lactone 1a (100 mg,
0.462 mmol) in Et2O (4.6 mL) at 0 C. After 30min the reaction vessel
was opened and 1 MHCl was added. The mixture was extracted with
CHCl3 (310 mL), the combined organic fractions were washed with
NaHCO3 (10 mL) and brine (10 mL), and then dried (MgSO4) and
concentrated. The crude product was puriﬁed by ﬁltration through
a short pad of silica gel with the aid of CH2Cl2. The title product was
obtained as a colourless oil (80 mg, 0.365 mmol, 79%). 1H NMR
(500 MHz, CDCl3) d 1.26 (s, 3 H, CH3), 1.60e1.67 (m, 2 H,
CH2CH2CH2OH), 1.69e1.78 (m, 2 H, CH2CH2CH2OH), 2.37e2.48 (m,
2 H, CH2CH]CHPh), 3.70 (t, J¼6.0 Hz, 2 H, CH2CH2CH2OH), 6.29 (dt,
J¼15.8, 7.6 Hz, 1 H, CH]CHPh), 6.48 (d, J¼15.8 Hz, 1 H, CH]CHPh),
7.24 (tt, J¼7.4, 1.6 Hz,1 H, ArH), 7.29e7.35 (m, 2 H, ArH), 7.36e7.41 (m,
2 H, ArH) ppm; 13C NMR (100 MHz, CDCl3) d 26.9 (CH3), 27.1
(CH2CH2CH2OH), 38.6 (CH2CH2CH2OH), 45.9 (CH2CH]CHPh), 63.4
(CH2CH2CH2OH), 72.4 (COH), 125.3 (CH]CHPh), 126.1 (ArCH), 127.3
(ArCH), 128.6 (ArCH), 133.8 (CH]CHPh), 137.2 (ArC) ppm; IR nmax
(neat/cm1): 3331 (OeH), 3026, 2934, 1448, 1374, 1056, 1015, 967;
HRMS calcd for C14H20O2Na [MþNa]þ: 243.1356, found 243.1350.
6.4. General procedure B: lactone radical cyclisation
All lactone radical cyclisations were carried out with and
without HMPA. For a detailed description of the procedure without
HMPA see the preparation of 6a. For a detailed description of the
procedure using HMPA as an additive see the preparation of 6c.
6.4.1. trans-2-Benzyl-4-hydroxy-4-methylcyclohexan-1-one (6a). To
a ﬂask charged with 0.1 M SmI2 in THF28 (18.6 mL, 1.86 mmol) was
added degassed distilled H2O (3.3 mL, 186 mmol). The resulting
deep red solution was stirred for 5 min before adding dropwise
a solution of lactone 1a (50 mg, 0.232 mmol) in THF (0.5 mL). The
mixture was stirred at room temperature until it decolourized.
Rochelle’s salt saturated solution was added and the mixture was
extracted with Et2O (315 mL) and the combined organic layers
were washed with brine, dried (MgSO4) and concentrated under
vacuum. The resulting crude diol was dissolved in dry CH2Cl2
(3.0 mL) and DesseMartin periodinane (156 mg, 0.368 mmol) was
added in one portion and the resulting mixture was stirred at
room temperature. After 7 h another portion of DesseMartin
periodinane (100 mg, 0.245 mmol) was added. The mixture was
stirred for 1 h before being quenched with a mixture of saturated
aqueous solution Na2S2O3/NaHCO3 (1:1, 10 mL). Layers were sep-
arated and the aqueous fraction was extracted with CH2Cl2
(310 mL). The combined organic layers were dried (MgSO4) and
concentrated under vacuum. The resulting crude mixture was
puriﬁed by silica gel column chromatography (hexane/EtOAc,
90:10 to 85:15). The title product was obtained as a 88:12 mixture
of diastereomers (26 mg, 0.118 mmol, 51%). The major di-
astereomer could be isolated and was obtained as colourless
crystals: mp (CH2Cl2) 79e81 C. 1H NMR (400 MHz, CDCl3) d 1.29
(s, 3 H, CH3), 1.52 (t, J¼13.4 Hz, 1 H, CHaHbCHC(O)), 1.83 (td, J¼13.7,
4.6 Hz, 1 H, CHaHbCH2C(O)), 1.89e2.05 (m, 2 H, CHaHbCHC(O)þ
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2.38 (dd, J¼14.1, 8.8 Hz, 1 H, CHaHbPh), 2.83 (td, J¼13.7, 6.0 Hz, 1 H,
CHaHbC(O)), 3.02e3.13 (m, 1 H, CHC(O)), 3.27 (dd, J¼14.1, 4.6 Hz,
1 H, CHaHbPh), 7.12e7.22 (m, 3 H, ArH), 7.24e7.31 (m, 2 H, ArH)
ppm; 13C NMR (100 MHz, CDCl3) d 30.5 (CH3), 34.7 (CH2Ph), 37.4
(CH2CH2C(O)), 39.6 (CH2CH2C(O)), 45.3 (CCH2CH), 46.6 (CHC(O)),
69.1 (C), 126.0 (ArCH), 128.3 (ArCH), 129.1 (ArCH), 140.1 (ArC),
212.5 (C(O)) ppm; IR nmax (neat/cm1): 3369 (OeH), 2965, 2935,
2918, 2852, 1686 (C]O), 1407, 1262, 1186; HRMS calcd for
C14H19O2 [MþH]þ: 219.1380, found 219.1380.
6.4.2. trans-2-(2-Chlorobenzyl)-4-hydroxy-4-methylcyclohexan-1-
one (6b). Prepared according to general procedure B (see prepa-
ration of 6a) using 1b (40 mg, 0.16 mmol), 0.1 M SmI2 in THF
(12.8 mL, 1.28 mmol) and H2O (2.3 mL, 128 mmol). The diol product
was then oxidised using DesseMartin periodinane (102 mg,
0.24 mmol) in CH2Cl2 (2.0 mL). The resulting crude mixture was
puriﬁed by silica column chromatography (hexane/EtOAc, 90:10 to
85:15). The title product was obtained as a 93:7 mixture of di-
astereomers (21 mg, 0.0832 mmol, 52%). The major diastereomer
could be isolated and was obtained as colourless crystals: mp
(CH2Cl2) 140e142 C. 1H NMR (400 MHz, CDCl3) d 1.31 (s, 3 H, CH3),
1.62 (t, J¼13.4 Hz, 1 H, CHaHbCHC(O)), 1.80e1.96 (m, 2 H,
CHaHbCH2C(O)þCHaHbCHC(O)), 1.97e2.05 (m, 1 H, CHaHbCH2C(O)),
2.28 (ddd, J¼13.8, 4.6, 2.2 Hz, 1 H, CHaHbC(O)), 2.54 (dd, J¼13.8,
8.6 Hz, 1 H, CHaHbAr), 2.84 (td, J¼13.8, 6.4 Hz, 1 H, CHaHbC(O)),
3.15e3.25 (m, 1 H, CHC(O)), 3.36 (dd, J¼13.8, 5.4 Hz, 1 H, CHaHbAr),
7.12e7.21 (m, 2 H, ArH), 7.24 (dd, J¼7.2, 2.0 Hz, 1 H, ArH), 7.34 (dd,
J¼7.4, 1.8 Hz, 1 H, ArH) ppm; 13C NMR (100 MHz, CDCl3) d 30.5
(CH3), 32.5 (CH2Ar), 37.4 (CH2CH2C(O)), 39.7 (CH2CH2C(O)), 45.0
(CCH2CH), 45.5 (CHC(O)), 69.2 (C), 126.6 (ArCH), 127.5 (ArCH), 129.5
(ArCH),131.6 (ArCH),134.2 (ArCCl), 137.8 (ArC), 212.2 (C(O)) ppm; IR
nmax (neat/cm1): 3385 (OeH), 2962, 2927, 1710 (C]O), 1470, 1436,
1132; HRMS calcd for C14H17O2ClNa [MþNa]þ: 275.0809, found
275.0809.
6.4.3. trans-2-(2-Fluorobenzyl)-4-hydroxy-4-methylcyclohexan-1-
one (6c). To a ﬂask charged with 0.1 M SmI2 in THF (17.1 mL,
1.71 mmol) were added degassed distilled H2O (3.1 mL,
171 mmol) and HMPA (2.4 mL, 13.7 mmol). The resulting deep red
solution was stirred for 5 min before adding dropwise a solution
of lactone 1c (50 mg, 0.213 mmol) in THF (0.5 mL). The mixture
was stirred at room temperature until it decolourized. Rochelle’s
salt saturated solution was added and the mixture was extracted
with Et2O (315 mL) and the combined organic layers were
washed with 1 N HCl, saturated aqueous NaHCO3 and brine, dried
(MgSO4), and concentrated under vacuum. The resulting crude
diol was dissolved in dry CH2Cl2 (2.3 mL) and DesseMartin
periodinane (115 mg, 0.271 mmol) was added in one portion and
the resulting mixture was stirred at room temperature. The
mixture was stirred for 4 h before being quenched with a mixture
of saturated aqueous solution Na2S2O3/NaHCO3 (1:1, 10 mL).
Layers were separated and the aqueous fraction was extracted
with CH2Cl2 (310 mL). The combined organic layers were dried
(MgSO4) and concentrated under vacuum. The resulting crude
mixture was puriﬁed by silica gel column chromatography (hex-
ane/EtOAc, 90:10 to 85:15). The title product was obtained as
a 93:7 mixture of diastereomers (24 mg, 0.102 mmol, 48%). The
major diastereomer could be isolated and was obtained as a white
solid: mp (CH2Cl2) 69e72 C. 1H NMR (400 MHz, CDCl3) d 1.29 (s,
3 H, CH3), 1.57 (t, J¼13.4 Hz, 1 H, CHaHbCHC(O)), 1.78e2.07 (m,
3 H, CHaHbCHC(O)þCH2CH2C(O)), 2.27 (ddd, J¼13.8, 4.6, 2.2 Hz,
1 H, CHaHbC(O)), 2.49 (dd, J¼13.9, 9.0 Hz, 1 H, CHaHbAr), 2.82 (td,
J¼13.8, 6.0 Hz, 1 H, CHaHbC(O)), 3.05e3.16 (m, 1 H, CHC(O)), 3.21
(dd, J¼13.9, 4.4 Hz, 1 H, CHaHbAr), 6.96e7.09 (m, 2 H, ArH),
7.14e7.23 (m, 2 H, ArH) ppm; 13C NMR (100 MHz, CDCl3) d 28.0 (d,J¼1.9 Hz, CH2Ar), 30.4 (CH3), 37.4 (CH2CH2C(O)), 39.6
(CH2CH2C(O)), 45.2 (CCH2CH), 45.4 (CHC(O)), 69.1 (C), 115.2 (d,
J¼22.1 Hz, ArCH), 123.9 (d, J¼3.5 Hz, ArCH); 126.9 (d, J¼15.6 Hz,
ArC); 127.8 (d, J¼8.0 Hz, ArCH), 131.6 (d, J¼4.9 Hz, ArCH), 161.3 (d,
J¼243.2 Hz, ArCF), 212.4 (C(O)) ppm; IR nmax (neat/cm1): 3352
(OeH), 2967, 2930, 1705 (C]O), 1490, 1228, 1112; HRMS calcd for
C14H17O2FNa [MþNa]þ: 259.1110, found 259.1109.
6.4.4. trans-4-Hydroxy-4-methyl-2-(4-(triﬂuoromethyl)benzyl)cy-
clohexan-1-one (6d). Prepared according to general procedure B
(see preparation of 6c) using 1d (20 mg, 0.07 mmol), 0.1 M SmI2 in
THF (5.6 mL, 0.56 mmol), H2O (1.0 mL, 56.0 mmol) and HMPA
(780 mL, 4.48 mmol). The diol product was then oxidised using
DesseMartin periodinane (45 mg, 0.105 mmol) in CH2Cl2 (1.0 mL).
The resulting crude mixture was puriﬁed by silica column chro-
matography (hexane/EtOAc, 90:10). The title product was obtained
as a 82:18 mixture of diastereomers (13 mg, 0.0455 mmol, 65%).
The major diastereomer could be isolated and was obtained as
a colourless oil. 1H NMR (400MHz, CDCl3) d 1.31 (s, 3 H, CH3),1.54 (t,
J¼13.2 Hz, 1 H, CHaHbCHC(O)), 1.79e2.07 (m, 3 H, CH2CH2C(O)þ
CHaHbCHC(O)), 2.29 (ddd, J¼13.6, 4.8, 2.4 Hz, 1 H, CHaHbC(O)),
2.41e2.50 (m, 1 H, CHaHbAr), 2.83 (td, J¼14.0, 6.0 Hz, 1 H,
CHaHbC(O)), 3.05e3.17 (m, 1 H, CHC(O)), 3.28 (dd, J¼14.0, 5.2 Hz,
1 H, CHaHbAr), 7.29 (d, J¼8.2 Hz, 2 H, ArH), 7.53 (d, J¼8.2 Hz, 2 H,
ArH) ppm; 13C NMR (100 MHz, CDCl3) d 30.5 (CH3), 34.7 (CH2Ar),
37.4 (CH2CH2C(O)), 39.7 (CH2CH2C(O)), 45.4 (CCH2CH), 46.4
(CHC(O)), 69.2 (C), 125.3 (q, J¼3.8 Hz, ArCH), 126.7 (q, J¼263.9 Hz,
CF3), 129.5 (ArCH), 144.4 (ArC), 212.0 (C(O)) ppm, ArCCF3 not ob-
served; IR nmax (neat/cm1): 3436 (OeH), 2928, 1707 (C]O), 1323,
1114, 1066; HRMS calcd for C15H16O2F3 [MH]: 285.1102, found
285.1106.
6.4.5. trans-2-(4-Bromobenzyl)-4-hydroxy-4-methylcyclohexan-1-
one (6e). Prepared according to general procedure B (see prepa-
ration of 6c) using 1e (21 mg, 0.07 mmol), 0.1 M SmI2 in THF
(5.6 mL, 0.56 mmol), H2O (1.0 mL, 56.0 mmol) and HMPA (780 mL,
4.48 mmol). The diol product was then oxidised using DesseMartin
periodinane (45 mg, 0.105 mmol) in CH2Cl2 (1.0 mL). The resulting
crude mixture was puriﬁed by silica column chromatography
(hexane/EtOAc, 90:10). The title product was obtained as a 90:10
mixture of diastereomers (17 mg, 0.0553 mmol, 79%). The major
diastereomer could be isolated and was obtained as a white solid:
mp (CH2Cl2) 113e115 C. 1H NMR (400 MHz, CDCl3) d 1.30 (s, 3 H,
CH3), 1.51 (t, J¼13.4 Hz, 1 H, CHaHbCHC(O)), 1.78e2.04 (m, 3 H,
CHaHbCHC(O)þCH2CH2C(O)), 2.27 (ddd, J¼13.7, 4.8, 2.4 Hz, 1 H,
CHaHbC(O)), 2.36 (dd, J¼14.0, 8.0 Hz, 1 H, CHaHbAr), 2.82 (tdd,
J¼13.7, 6.2, 1.0 Hz, 1 H, CHaHbC(O)), 2.99e3.10 (m, 1 H, CHC(O)), 3.18
(dd, J¼14.0, 5.2 Hz, 1 H, CHaHbAr), 7.05 (d, J¼7.6 Hz, 2 H, ArH), 7.39
(d, J¼7.6 Hz, 2 H, ArH) ppm; 13C NMR (100MHz, CDCl3) d 30.5 (CH3),
34.2 (CH2Ar), 37.4 (CH2CH2C(O)), 39.7 (CH2CH2C(O)), 45.3
(CCH2CH), 46.5 (CHC(O)), 69.2 (C), 119.8 (ArCBr), 130.9 (ArCH), 131.4
(ArCH), 139.1 (ArC), 212.2 (C(O)) ppm; IR nmax (neat/cm1): 3442
(OeH), 2964, 2927, 1704 (C]O), 1488, 1145, 1071, 1011; MS was
uninformative.
6.4.6. trans-4-Hydroxy-4-methyl-2-(4-methylbenzyl)cyclohexan-1-
one (6f). Prepared according to general procedure B (see prepara-
tion of 6c) using 1f (16 mg, 0.07 mmol), 0.1 M SmI2 in THF (5.6 mL,
0.56 mmol), H2O (1.0 mL, 56.0 mmol) and HMPA (780 mL,
4.48 mmol). The diol product was then oxidised using DesseMartin
periodinane (45 mg, 0.105 mmol) in CH2Cl2 (1.0 mL). The resulting
crude mixture was puriﬁed by silica column chromatography
(hexane/EtOAc, 90:10). The title product was obtained as a 91:9
mixture of diastereomers (9 mg, 0.0384 mmol, 56%). The major
diastereomer could be isolated and was obtained as a white solid:
mp (CH2Cl2) 93e96 C. 1H NMR (400 MHz, CDCl3) d 1.29 (s, 3 H,
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1 H, CHaHbCH2C(O)), 1.89e2.04 (m, 2 H, CHaHbCHC(O)þ
CHaHbCH2C(O)), 2.27 (ddd, J¼13.7, 4.6, 2.2 Hz, 1 H, CHaHbC(O)),
2.31e2.38 (m, 4 H, ArCH3þCHaHbAr), 2.82 (tdd, J¼13.7, 6.2, 1.0 Hz,
1 H, CHaHbC(O)), 2.99e3.11 (m, 1 H, CHC(O)), 3.22 (dd, J¼14.4,
4.8 Hz, 1 H, CHaHbAr), 7.05 (d, J¼8.0 Hz, 2 H, ArH), 7.09 (d, J¼8.0 Hz,
2 H, ArH) ppm; 13C NMR (100 MHz, CDCl3) d 21.0 (ArCH3), 30.5
(CH3), 34.3 (CH2Ar), 37.5 (CH2CH2C(O)), 39.6 (CH2CH2C(O)), 45.3
(CCH2CH), 46.6 (CHC(O)), 69.2 (C), 129.0 (ArCH), 129.0 (ArCH), 135.4
(ArC), 136.9 (ArC), 212.7 (C(O)) ppm; IR nmax (neat/cm1): 3441
(OeH), 2964, 2925, 1703 (C]O), 1515, 1144; HRMS calcd for
C15H20O2Na [MþNa]þ: 255.1356, found 255.1348.
6.4.7. trans-4-Hydroxy-4-methyl-2-(3-methylbenzyl)cyclohexan-1-
one (6g). Prepared according to general procedure B (see prepa-
ration of 6c) using 1g (50 mg, 0.217 mmol), 0.1 M SmI2 in THF
(17.4 mL, 1.74 mmol), H2O (3.1 mL, 174 mmol) and HMPA (2.4 mL,
13.9 mmol). The diol product was then oxidised using DesseMartin
periodinane (119 mg, 0.281 mmol) in CH2Cl2 (2.3 mL). The resulting
crude mixture was puriﬁed by silica column chromatography
(hexane/EtOAc, 90:10 to 85:15). The title product was obtained as
a 91:9 mixture of diastereomers (29 mg, 0.126 mmol, 58%). The
major diastereomer could be isolated and was obtained as a white
solid: mp (CH2Cl2) 71e73 C. 1H NMR (400 MHz, CDCl3) d 1.30 (s,
3 H, CH3), 1.52 (t, J¼13.6 Hz, 1 H, CHaHbCHC(O)), 1.84 (td, J¼13.9,
4.8 Hz, 1 H, CHaHbCH2C(O)), 1.89e2.05 (m, 2 H, CHaHbCHC(O)þ
CHaHbCH2C(O)), 2.24e2.37 (m, 5 H, CHaHbC(O)þCHaHbArþArCH3),
2.83 (td, J¼13.9, 6.4 Hz,1 H, CHaHbC(O)), 3.01e3.12 (m,1 H, CHC(O)),
3.24 (dd, J¼14.2, 4.6 Hz,1 H, CHaHbAr), 6.93e6.99 (m, 2 H, ArH), 7.01
(d, J¼7.4 Hz, 1 H, ArH), 7.17 (t, J¼7.4 Hz, 1 H, ArH) ppm; 13C NMR
(100 MHz, CDCl3) d 21.4 (ArCH3), 30.5 (CH3), 34.6 (CH2Ar), 37.4
(CH2CH2C(O)), 39.6 (CH2CH2C(O)), 45.3 (CCH2CH), 46.6 (CHC(O)),
69.2 (C), 126.1 (ArCH), 126.7 (ArCH), 128.2 (ArCH), 129.9 (ArCH),
137.9 (ArC), 140.0 (ArC), 212.7 (C(O)) ppm; IR nmax (neat/cm1):
3383 (OeH), 2965, 2930, 2853, 1686 (C]O), 1605, 1136; HRMS
calcd for C15H20O2Na [MþNa]þ: 255.1361, found 255.1359.
6.4.8. trans-2-(2,5-Dimethylbenzyl)-4-hydroxy-4-methylcyclohexan-
1-one (6h). Prepared according to general procedure B (see prep-
aration of 6c) using 1h (17 mg, 0.07 mmol), 0.1 M SmI2 in THF
(5.6 mL, 0.56 mmol), H2O (1.0 mL, 56.0 mmol) and HMPA (780 mL,
4.48 mmol). The diol product was then oxidised using DesseMartin
periodinane (45 mg, 0.105 mmol) in CH2Cl2 (1.0 mL). The resulting
crude mixture was puriﬁed by silica column chromatography
(hexane/EtOAc, 90:10). The title product was obtained as a 88:12
mixture of diastereomers (7 mg, 0.0287 mmol, 41%). The major
diastereomer could be isolated and was obtained as a colourless oil.
1H NMR (400MHz, CDCl3) d 1.31 (s, 3 H, CH3), 1.57 (t, J¼13.2 Hz, 1 H,
CHaHbCHC(O)), 1.85 (td, J¼13.9, 4.8 Hz, 1 H, CHaHbCH2C(O)),
1.90e2.06 (m, 2 H, CHaHbCHC(O)þCHaHbCH2C(O)), 2.24 (s, 3 H,
ArCH3), 2.26e2.36 (m, 5 H, ArCH3þCHaHbC(O)þCHaHbAr), 2.84 (td,
J¼13.9, 6.4 Hz, 1 H, CHaHbC(O)), 2.99e3.11 (m, 1 H, CHC(O)), 3.28
(dd, J¼14.2, 4.2 Hz, 1 H, CHaHbAr), 6.87e6.96 (m, 2 H, ArH), 7.03 (d,
J¼7.6 Hz, 1 H, ArH) ppm; 13C NMR (100 MHz, CDCl3) d 19.1 (ArCH3),
21.0 (ArCH3), 30.5 (CH3), 31.7 (CH2Ar), 37.5 (CH2CH2C(O)), 39.7
(CH2CH2C(O)), 45.5 (CHC(O)), 45.5 (CCH2CH), 69.2 (C), 126.8 (ArCH),
130.2 (ArCH), 130.6 (ArCH), 133. (ArC), 135.1 (ArC), 138.1 (ArC), 212.7
(C(O)) ppm; IR nmax (neat/cm1): 3441 (OeH), 2963, 2926, 1704
(C]O), 1454, 1234, 1143; HRMS calcd for C16H22O2Na [MþNa]þ:
269.1512, found 269.1505.
6.4.9. trans-4-Hydroxy-4-methyl-2-(naphthalen-2-ylmethyl)cyclo-
hexan-1-one (6i). Prepared according to general procedure B (see
preparation of 6c) using 1i (20 mg, 0.07 mmol), 0.1 M SmI2 in THF
(5.6 mL, 0.56 mmol), H2O (1.0 mL, 56.0 mmol) and HMPA (780 mL,
4.48 mmol). The diol product was then oxidised using DesseMartinperiodinane (45 mg, 0.105 mmol) in CH2Cl2 (1.0 mL). The resulting
crude mixture was puriﬁed by silica column chromatography
(hexane/EtOAc, 90:10). The title product was obtained as a 86:14
mixture of diastereomers (7 mg, 0.0259 mmol, 37%). The major
diastereomer could be isolated and was obtained as a colourless oil.
1H NMR (400MHz, CDCl3) d 1.27 (s, 3 H, CH3), 1.57 (t, J¼13.4 Hz, 1 H,
CHaHbCHC(O)), 1.85 (td, J¼13.8, 4.8 Hz, 1 H, CHaHbCH2C(O)),
1.90e2.07 (m, 2 H, CHaHbCHC(O)þCHaHbCH2C(O)), 2.30 (ddd,
J¼13.8, 4.6, 2.4 Hz, 1 H, CHaHbC(O)), 2.56 (dd, J¼14.2, 9.0 Hz, 1 H,
CHaHbAr), 2.80e2.87 (m, 1 H, CHaHbC(O)), 3.13e3.24 (m, 1 H,
CHC(O)), 3.43 (dd, J¼14.2, 4.6 Hz, 1 H, CHaHbAr), 7.29e7.35 (m, 1 H,
ArH), 7.40e7.51 (m, 2 H, ArH), 7.60 (br s, 1 H, ArH), 7.75e7.84 (m,
3 H, ArH) ppm; 13C NMR (100 MHz, CDCl3) d 30.5 (CH3), 34.9
(CH2Ar), 37.5 (CH2CH2C(O)), 39.6 (CH2CH2C(O)), 45.3 (CCH2CH),
46.6 (CHC(O)), 69.2 (C), 125.2 (ArCH), 125.9 (ArCH), 127.4 (ArCH),
127.4 (ArCH), 127.6 (ArCH), 127.6 (ArCH), 128.0 (ArCH), 132.0 (ArC),
133.5 (ArC), 137.6 (ArC), 212.5 (C(O)) ppm; IR nmax (neat/cm1):
3440 (OeH), 3051, 2964, 2928, 1707 (C]O), 1236; HRMS calcd for
C18H20O2Na [MþNa]þ: 291.1356, found 291.1348.Acknowledgements
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